Texas health department appoints anti-abortion OB-GYN to maternal mortality committee
Advertisement
Read this article for free:
or
Already have an account? Log in here »
To continue reading, please subscribe:
Monthly Digital Subscription
$1 per week for 24 weeks*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $4.00 plus GST every four weeks. After 24 weeks, price increases to the regular rate of $19.00 plus GST every four weeks. Offer available to new and qualified returning subscribers only. Cancel any time.
Monthly Digital Subscription
$4.75/week*
- Enjoy unlimited reading on winnipegfreepress.com
- Read the E-Edition, our digital replica newspaper
- Access News Break, our award-winning app
- Play interactive puzzles
*Billed as $19 plus GST every four weeks. Cancel any time.
To continue reading, please subscribe:
Add Winnipeg Free Press access to your Brandon Sun subscription for only
$1 for the first 4 weeks*
*$1 will be added to your next bill. After your 4 weeks access is complete your rate will increase by $0.00 a X percent off the regular rate.
Read unlimited articles for free today:
or
Already have an account? Log in here »
Hey there, time traveller!
This article was published 22/05/2024 (496 days ago), so information in it may no longer be current.
AUSTIN, Texas (AP) — Texas’ health department has appointed an outspoken anti-abortion OB-GYN to a committee that reviews pregnancy-related deaths as doctors have been warning that the state’s restrictive abortion ban puts women’s lives at risk.
Dr. Ingrid Skop was among the new appointees to the Texas Maternal Morality and Morbidity Review Committee announced last week by the Texas Department of State Health Services. Her term starts June 1.
The committee, which compiles data on pregnancy-related deaths, makes recommendations to the Legislature on best practices and policy changes and is expected to assess the impact of abortion laws on maternal mortality.

Skop, who has worked as an OB-GYN for over three decades, is vice president and director of medical affairs for the Charlotte Lozier Institute, an anti-abortion research group. Skop will be the committee’s rural representative.
Skop, who has worked in San Antonio for most of her career, told the Houston Chronicle that she has “often cared for women traveling long distances from rural Texas maternity deserts, including women suffering complications from abortions.”
Texas has one of the most restrictive abortion bans in the U.S., and doctors have sought clarity on the state’s medical exemption, which allows an abortion to save a woman’s life or prevent the impairment of a major bodily function. Doctors have said the exemption is too vague, making it difficult to offer life-saving care for fear of repercussions. A doctor convicted of providing an illegal abortion in Texas can face up to 99 years in prison and a $100,000 fine and lose their medical license.
Skop has said medical associations are not giving doctors the proper guidance on the matter. She has also shared more controversial views, saying during a congressional hearing in 2021 that rape or incest victims as young as 9 or 10 could carry pregnancies to term.
Texas’ abortion ban has no exemption for cases of rape or incest.
The American College of Obstetricians and Gynecologists, which says abortion is “inherently tied to maternal health,” said in a statement that members of the Texas committee should be “unbiased, free of conflicts of interest and focused on the appropriate standards of care.” The organization noted that bias against abortion has already led to “compromised” analyses, citing a research articles co-authored by Skop and others affiliated with the Charlotte Lozier Institute.
Earlier this year a medical journal retracted studies supported by the Charlotte Lozier Institute claiming to show harms of the abortion pill mifepristone, citing conflicts of interests by the authors and flaws in their research. Two of the studies were cited in a pivotal Texas court ruling that has threatened access to the drug.